Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Remedy Q1'25 flash comment: Good start to the year ahead of FBC: Firebreak release

By Atte RiikolaAnalyst
Remedy Entertainment

Translation: Original published in Finnish on 04/30/2025 at 09:25 am EEST Remedy300425Remedy reported clearly better-than-expected Q1 earnings this morning. There were more development fees than we expected in Q1, and the company's cost structure was also lighter than we expected. Alan Wake 2’s royalties evolved in line with our expectations, and the game continues to generate stable sales, according to the company. All game projects have progressed at a good pace in Q1 according to the compay and FBC: Firebreak's release (June 17) is already around the corner. Overall, the Q1 report was an encouraging start to the year, as our earnings expectations have focused on the end of the year for 2025.

Revenue exceeded our expectations in terms of development fees

Remedy’s Q1 revenue grew by 24% to 13.4 MEUR which exceeded our 11.6 MEUR estimate. As expected, development fees (Q1'25: 10.7 MEUR) accounted for most of revenue, but more of them were recognized as revenue in Q1 than we had expected. We believe most development fees came from the Max Payne subcontracting project that was in production. Control 2, which entered full production in February, has apparently also generated more development fees than we expected (Annapurna finances 50% of the estimated production budget of around 50 MEUR).

Royalties in Q1 were 2.6 MEUR, which was exactly what we expected. According to Remedy, most of these were related to Alan Wake 2 royalties, which was what we expected. According to the company, Alan Wake 2 continues to sell steadily and accumulate royalties. At the turn of last year, the game's sales exceeded 2 million copies, but the figure was not updated at this point.

Q1 earnings clearly better than our estimates

In Q1, Remedy’s EBITDA was 2.6 MEUR (Q1’24 -1.2 MEUR), exceeding our forecast of -0.9 MEUR clearly. Due to the fixed cost structure, the revenue overshoot is reflected directly in earnings lines, and the cost structure was overall lighter than we predicted in Q1. In particular, outsourcing costs were lower than expected in Q1. In our estimates, Remedy’s earnings expectations are focused on H2 this year, as  FBC: Firebreak to be released on June 17, starts to generate revenue for the company. Relative to this, the development in Q1 was promising.

As expected, outlook remains unchanged at this point of the year

In its guidance, Remedy estimates revenue (2024: 50.7 MEUR) and EBIT (-4.3 MEUR) to increase compared to the previous year and that EBIT will be positive. The focus for growth is naturally on the release of FBC: Firebreak, but in addition, the royalties from Alan Wake 2 and other older games create a base for revenue. Remedy has strengthened its self-publishing team to best support sales of already released older games in digital channels. The Max Payne project and Control 2 will continue to generate significant development fees this year. Our forecast before the report expected revenue of 65.8 MEUR (+30%) and EBIT of 1.7 MEUR for this year. With the earnings overshoot in Q1, there is some upside pressure in the estimates. In the big picture, medium-term performance expectations are weighted towards 2027, when Control 2 is very likely to be released.

 

Remedy Entertainment is a game developer. Its operations are primarily focused on the development of action games, with a particular focus on 3D technology. Examples of games that the company has developed include several different versions of Alan Wake, Max Payne, and Control. Remedy also develops its own game engine and tooling technology that powers many of its games. The company was founded in 1995 and is headquartered in Espoo, Finland.

Read more on company page

Key Estimate Figures12.02

202425e26e
Revenue50.765.871.9
growth-%49.3 %29.9 %9.2 %
EBIT (adj.)-4.31.72.4
EBIT-% (adj.)-8.4 %2.6 %3.3 %
EPS (adj.)-0.270.100.14
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.146.6106.3
EV/EBITDA65.922.014.5

Forum discussions

To extend the brand, let’s add more tinfoil hat theories and speculation. Earlier this week, Sami Järvi posted a picture on Instagram with musician...
12/5/2025, 10:32 AM
by Akee
26
Get your tin foil hats out and let the speculation begin. Remedy’s law firm yesterday registered the trademark CONTROL Resonant. ![image|690x268...
11/28/2025, 1:11 AM
by Trivial
44
Firebreak now has voice chat, but it’s probably too little too late. store.steampowered.com – 19 Nov 25 FBC: Firebreak - Patch Notes v1.7.1 ...
11/19/2025, 1:10 PM
by Akee
15
TakeTwo also has other similar development projects in its pipeline, such as Ken Levine’s “Bioshock in space” - JUDAS, which was supposed to...
11/12/2025, 1:28 PM
by Trivial
13
Isa and Atte chatted in English about Remedy regarding Q3. Inderes Remedy Q3’25: Upcoming games in focus - Inderes Time: 12.11.2025 klo 12.29...
11/12/2025, 12:54 PM
by Sijoittaja-alokas
7
Yes, there would definitely be a spot for Max Payne, and even if there aren’t huge profits available, there’s even more fame for Remedy. My ...
11/7/2025, 4:34 AM
by Arvuuttaja
10
Let’s put this in the Remedy thread too. GTA VI is delayed to late 2026. Rockstar Games Grand Theft Auto VI is Now Set to Launch November 19...
11/6/2025, 9:28 PM
by Akee
13
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.